  |
         |
 |
 |
|
University of
Ottawa
Knowledge Translation Workshop
Tabaret Hall, 550 Cumberland Street, Room 083
November 25-26, 2007
Knowledge Translation in the Post
Market Evaluation
of Drug Safety and Effectiveness Data
Workshop participants
Sunday November 25, 2007
7:05pm
Workshop Objectives
Noralou Roos, University of Manitoba
Noralou_Roos@cpe.umanitoba.ca
7:15pm
Keynote speaker – Principles of Knowledge Translation
Jeremy Grimshaw, OHRI & University of Ottawa
jgrimshaw@ohri.ca
Monday November 26, 2007
8:30am
National Pharmaceutical Strategy (NPS) context
Abby Hoffman, Health Canada
Abby_Hoffman@hc-sc.gc.ca
9:00am
Improving knowledge translation on medication harms and benefits
Anne Holbrook, McMaster University
holbrook@mcmaster.ca
9:30am
Innovative approaches to fostering behavioural
change
Lisa Dolovich, McMaster University
ldolovic@mcmaster.ca
- View Slides
10:30am
Communicating with Health Professionals and the Public
Vicky Hogan, Health Canada
Vicky_Hogan@hc-sc.gc.ca
11:00am
COMPUS – Early Experiences in KT – Evidence
to Implementation
Bill Leslie, CADTH
BillL@cadth.ca
11:30am
Discussant
James McCormack, University of British Columbia (UBC)
jmccorma@interchange.ubc.ca
1:00pm
Panel Discussion «Knowledge Translation Needs in Communicating
Drug Risks and Effectiveness in Canada»
Panel Members:
Carol Repchinsky, Canadian Pharmacists
Association (CPhA)
crepchinsky@pharmacists.ca
Carol Kushner, Communications
ckushner@idirect.com
Brent Fraser, Drug Plan Group, Ministry of Health and Long Term-Care, Ontario
Cindy Evans, Health Canada, Therapeutic
Effectiveness and Policy Bureau, MHPD
cindy_evans@hc-sc.gc.ca
Judy Birdsell, Health Charities
Volunteer
birdsell@omhg.net
Madeline Boscoe, Patients/Public Group
ed@cwhn.ca
3:00pm
Breakout groups “Strenghten the Role
of Knowledge Translation (KT) in the Real-World
Drug Safety and Effectiveness
Charge to breakout groups, Madeline
Boscoe
Summary
Daniel Krewski, University of Ottawa
Online presentations from the KT Workshop are subject to copyright protection. Permission from the speaker is required prior to any copying, reproducing, or rebroadcasiting any portion of the speaker’s presentations.
The KT workshop was organized by a steering committee:
Workshop Steering Committee:
Barb Shea CADTH
Bill Leslie, CADTH
Brenda MacGibbon-Taylor, Patient representative. McGill University
Health Centre
Chris Turner, Health Canada
Colleen Metge, University of Manitoba
Craig Larsen, CADTH
Daniel Krewski, University of Ottawa
Daniel Bedard, University of Ottawa
Ian Graham, CIHR
Ingrid Sketris, Dalhousie
Jean Gray, Professor Emeritus, Dalhousie
Judy Birdsell, On Management Health Group, Alberta
Lisa Dolovich, McMaster University
Madeline Boscoe, Canadian Women’s Health Network
Muhammad Mamdani, University of Toronto
Noralou Roos, University of Manitoba
Robyn Tamblyn, McGill University
Susanne Reid, Health Canada
Vicky Hogan, Health Canada
Wayne Lepine, Health Canada
Wayne Nitchuk Health Canada
Sponsors
Canadian Agency for Drugs and Technologies in Health (CADTH)
Canadian Health Services Research Foundation (CHSRF)
Canadian Institutes Health Research (CIHR)/IHSPR
Canadian Patient Safety Institute (CPSI)
Health Canada/National Pharmaceutical Strategy
Exhibitors
Canadian Agency for Drugs and Technologies in Health (CADTH)
Canadian AIDS Treatment Information Exchange (CATIE)
Canadian Pharmacists Association (CPhA)
Canadian Women’s Health Network (CWHN)
Decision Support Tools (Annette O’Connor)
IMPACT Program (Lisa Dolovich)
MedEffect Program (Health Canada)
Therapeutics Initiative
 |